Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017-2019.
Population Clinical
Cessation
Tobacco
Chen (2022)
Electromembrane extraction of nicotine in inhaled aerosols from tobacco cigarettes, electronic cigarettes, and heated tobacco products.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Chen (2022)
Single-nucleus chromatin accessibility and RNa sequencing reveal impaired brain development in prenatally e-cigarette exposed neonatal rats.
Nonclinical
Genotoxicity
In Vivo
Chen (2022)
Increased Levels of the acrolein Metabolite 3-hydroxypropyl Mercapturic acid in the Urine of e-Cigarette Users.
Individual Clinical
Biomarkers
Biommarkers Of Exposure
Chen (2023)
Associations between living in localities with e-cigarette sales restrictions and e-cigarette use change among young adults in Los Angeles County.
Population Clinical
Consumer Use
Youth Use & Appeal
Chen-Sankey (2022)
health risks of dual use of electronic and combustible cigarettes: exposure to acrylamide and glycidamide.
Individual Clinical
Safety
Adverse Effects
Cheng (2022)
Increased acrolein-DNa adducts in buccal brushings of e-cigarette users.
Individual Clinical
Safety
Adverse Effects
Cheng (2022)
association of Vaping and Respiratory health among Youth in the Population assessment of Tobacco and health (PaTh) Study Wave 3.
Individual Clinical
Respiratory Toxicity
Relative Health Effect Of User
Cherian (2021)
Dependence motives of young adult users of electronic nicotine delivery systems.
Population Clinical
Consumer Use
Reasons For Use
Chesaniuk (2019)
E-Cigarette aerosol Condensate Leads to Impaired Coronary Endothelial Cell health and Restricted angiogenesis.
Nonclinical
Cardiovascular Toxicity
In Vitro
Chhor (2023)